On the public citation graph

Structural Optimization of siRNA Conjugates for Albumin Binding Achieves Effective MCL1-Targeted Cancer Therapy

0 signed · 72 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/anie.201209440openalex-snapshot
DNA Micelle Flares for Intracellular mRNA Imaging and Gene Therapy
inferredcites →https://doi.org/10.1002/chem.200901546openalex-snapshot
DNA‐Based Micelles: Synthesis, Micellar Properties and Size‐Dependent Cell Permeability
inferredcites →https://doi.org/10.1002/jcph.1480openalex-snapshot
Patisiran Pharmacokinetics, Pharmacodynamics, and Exposure‐Response Analyses in the Phase 3 APOLLO Trial in Patients With Hereditary Transthyretin‐Mediated (hATTR) Amyloidosis
inferredcites →https://doi.org/10.1007/s00280-008-0738-2openalex-snapshot
Use of cholesterol-rich nanoparticles that bind to lipoprotein receptors as a vehicle to paclitaxel in the treatment of breast cancer: pharmacokinetics, tumor uptake and a pilot clinical study
inferredcites →https://doi.org/10.1007/s10439-013-0895-2openalex-snapshot
A Physiological Perspective on the Use of Imaging to Assess the In Vivo Delivery of Therapeutics
inferredcites →https://doi.org/10.1007/s40120-020-00208-1openalex-snapshot
A Review of Patisiran (ONPATTRO®) for the Treatment of Polyneuropathy in People with Hereditary Transthyretin Amyloidosis
inferredcites →https://doi.org/10.1016/0022-4804(91)90240-mopenalex-snapshot
Identification of tissue sites for increased albumin degradation in sarcoma-bearing mice
inferredcites →https://doi.org/10.1016/0169-5002(93)90206-dopenalex-snapshot
Elevated uptake of low density lipoproteins by human lung cancer tissue in vivo
inferredcites →https://doi.org/10.1016/0883-2897(92)90103-6openalex-snapshot
Design of compounds having enhanced tumour uptake, using serum albumin as a carrier—part II. In vivo studies
inferredcites →https://doi.org/10.1016/j.addr.2015.01.008openalex-snapshot
Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides
inferredcites →https://doi.org/10.1016/j.addr.2018.07.011openalex-snapshot
Harnessing albumin as a carrier for cancer therapies
inferredcites →https://doi.org/10.1016/j.biomaterials.2010.05.027openalex-snapshot
The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation
inferredcites →https://doi.org/10.1016/j.biomaterials.2018.11.010openalex-snapshot
Dual carrier-cargo hydrophobization and charge ratio optimization improve the systemic circulation and safety of zwitterionic nano-polyplexes
inferredcites →https://doi.org/10.1016/j.biomaterials.2020.120528openalex-snapshot
Kupffer Cell Release of Platelet Activating Factor Drives Dose Limiting Toxicities of Nucleic Acid Nanocarriers
inferredcites →https://doi.org/10.1016/j.ijpharm.2021.120940openalex-snapshot
Antibody-siRNA conjugates (ARCs) using multifunctional peptide as a tumor enzyme cleavable linker mediated effective intracellular delivery of siRNA
inferredcites →https://doi.org/10.1016/j.jconrel.2008.05.010openalex-snapshot
Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
inferredcites →https://doi.org/10.1016/j.jconrel.2014.03.057openalex-snapshot
EPR: Evidence and fallacy
inferredcites →https://doi.org/10.1016/j.jconrel.2016.11.015openalex-snapshot
To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?
inferredcites →https://doi.org/10.1016/j.jconrel.2019.03.028openalex-snapshot
The valency of fatty acid conjugates impacts siRNA pharmacokinetics, distribution, and efficacy in vivo
inferredcites →https://doi.org/10.1016/j.jsb.2006.08.015openalex-snapshot
Effect of human serum albumin on drug metabolism: Structural evidence of esterase activity of human serum albumin
inferredcites →https://doi.org/10.1016/j.omtn.2016.12.011openalex-snapshot
Cholesterol-Containing Nuclease-Resistant siRNA Accumulates in Tumors in a Carrier-free Mode and Silences MDR1 Gene
inferredcites →https://doi.org/10.1016/j.omtn.2018.09.002openalex-snapshot
An Efficient Bivalent Cyclic RGD-PIK3CB siRNA Conjugate for Specific Targeted Therapy against Glioblastoma In Vitro and In Vivo
inferredcites →https://doi.org/10.1016/j.semcancer.2003.09.015openalex-snapshot
Oncogenic Ras and its role in tumor cell invasion and metastasis
inferredcites →https://doi.org/10.1016/j.stemcr.2018.01.005openalex-snapshot
A Non-apoptotic Function of MCL-1 in Promoting Pluripotency and Modulating Mitochondrial Dynamics in Stem Cells
inferredcites →https://doi.org/10.1016/j.ymthe.2017.05.009openalex-snapshot
Fatty Acid-Modified Gapmer Antisense Oligonucleotide and Serum Albumin Constructs for Pharmacokinetic Modulation
inferredcites →https://doi.org/10.1016/j.ymthe.2021.02.015openalex-snapshot
Centyrin ligands for extrahepatic delivery of siRNA
inferredcites →https://doi.org/10.1016/s0021-9258(17)37571-3openalex-snapshot
Albondin-mediated capillary permeability to albumin. Differential role of receptors in endothelial transcytosis and endocytosis of native and modified albumins.
inferredcites →https://doi.org/10.1016/s0021-9258(18)35799-5openalex-snapshot
Preferential interaction of albumin-binding proteins, gp30 and gp18, with conformationally modified albumins. Presence in many cells and tissues with a possible role in catabolism.
inferredcites →https://doi.org/10.1016/s0021-9258(18)53212-9openalex-snapshot
High affinity binding, endocytosis, and degradation of conformationally modified albumins. Potential role of gp30 and gp18 as novel scavenger receptors.
inferredcites →https://doi.org/10.1016/s0021-9258(19)41721-3openalex-snapshot
Long chain fatty acid binding to human plasma albumin.
inferredcites →https://doi.org/10.1016/s0026-895x(25)12512-1openalex-snapshot
Effects of Fatty Acids on Two Specific Drug Binding Sites on Human Serum Albumin
inferredcites →https://doi.org/10.1016/s1040-8428(97)00015-2openalex-snapshot
Plasma protein (albumin) catabolism by the tumor itself—implications for tumor metabolism and the genesis of cachexia
inferredcites →https://doi.org/10.1021/acs.accounts.9b00228openalex-snapshot
Survey of Clinical Translation of Cancer Nanomedicines—Lessons Learned from Successes and Failures
inferredcites →https://doi.org/10.1021/acs.bioconjchem.6b00437openalex-snapshot
Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer?
inferredcites →https://doi.org/10.1021/acs.biomac.5b00550openalex-snapshot
Cholesterol Modified Self-Assemblies and Their Application to Nanomedicine
inferredcites →https://doi.org/10.1021/acs.jmedchem.5b00726openalex-snapshot
Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide
inferredcites →https://doi.org/10.1021/bc800278eopenalex-snapshot
siRNA Conjugate Delivery Systems
inferredcites →https://doi.org/10.1021/jacs.7b02917openalex-snapshot
Development of DNA Nanostructures for High-Affinity Binding to Human Serum Albumin
inferredcites →https://doi.org/10.1021/jacs.9b13524openalex-snapshot
Origins of the Increased Affinity of Phosphorothioate-Modified Therapeutic Nucleic Acids for Proteins
inferredcites →https://doi.org/10.1021/jm049167jopenalex-snapshot
Fully 2‘-Modified Oligonucleotide Duplexes with Improved in Vitro Potency and Stability Compared to Unmodified Small Interfering RNA
inferredcites →https://doi.org/10.1021/jm070861jopenalex-snapshot
Structure−Activity and Protraction Relationship of Long-Acting Glucagon-like Peptide-1 Derivatives: Importance of Fatty Acid Length, Polarity, and Bulkiness
inferredcites →https://doi.org/10.1021/jp026479uopenalex-snapshot
Nile Red and DCM Fluorescence Anisotropy Studies in C12E7/DPPC Mixed Systems
inferredcites →https://doi.org/10.1021/jp0704822openalex-snapshot
Effect of Unsaturation in Fatty Acids on the Main Characteristics of Langmuir Monolayers
inferredcites →https://doi.org/10.1038/cddis.2014.561openalex-snapshot
Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)
inferredcites →https://doi.org/10.1038/nature12138openalex-snapshot
Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells
inferredcites →https://doi.org/10.1038/nature12978openalex-snapshot
Structure-based programming of lymph-node targeting in molecular vaccines
inferredcites →https://doi.org/10.1038/nature19830openalex-snapshot
The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models
inferredcites →https://doi.org/10.1038/nbt.1560openalex-snapshot
Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors
inferredcites →https://doi.org/10.1038/nbt1339openalex-snapshot
Mechanisms and optimization of in vivo delivery of lipophilic siRNAs
inferredcites →https://doi.org/10.1038/ncb2488openalex-snapshot
Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration
inferredcites →https://doi.org/10.1038/s42003-021-02564-6openalex-snapshot
The multiple mechanisms of MCL1 in the regulation of cell fate
inferredcites →https://doi.org/10.1039/c1cs15038copenalex-snapshot
Hybrid lipid oligonucleotide conjugates: synthesis, self-assemblies and biomedical applications
inferredcites →https://doi.org/10.1073/pnas.1621240114openalex-snapshot
Lipophilic siRNA targets albumin in situ and promotes bioavailability, tumor penetration, and carrier-free gene silencing
inferredcites →https://doi.org/10.1080/10717544.2016.1267821openalex-snapshot
A tumor-targeting cRGD-EGFR siRNA conjugate and its anti-tumor effect on glioblastoma in vitro and in vivo
inferredcites →https://doi.org/10.1089/nat.2018.0725openalex-snapshot
Improving siRNA Delivery In Vivo Through Lipid Conjugation
inferredcites →https://doi.org/10.1091/mbc.e15-01-0028openalex-snapshot
Mcl-1 involvement in mitochondrial dynamics is associated with apoptotic cell death
inferredcites →https://doi.org/10.1093/nar/gkaa595openalex-snapshot
The chemical structure and phosphorothioate content of hydrophobically modified siRNAs impact extrahepatic distribution and efficacy
inferredcites →https://doi.org/10.1093/nar/gkx818openalex-snapshot
Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc–siRNA conjugates
inferredcites →https://doi.org/10.1093/nar/gky1232openalex-snapshot
Hydrophobicity drives the systemic distribution of lipid-conjugated siRNAs via lipid transport pathways
inferredcites →https://doi.org/10.1093/nar/gky745openalex-snapshot
Functional features defining the efficacy of cholesterol-conjugated, self-deliverable, chemically modified siRNAs
inferredcites →https://doi.org/10.1093/nar/gkz354openalex-snapshot
Fatty acid conjugation enhances potency of antisense oligonucleotides in muscle
inferredcites →https://doi.org/10.1158/0008-5472.can-14-2211openalex-snapshot
Human Pancreatic Cancer Tumors Are Nutrient Poor and Tumor Cells Actively Scavenge Extracellular Protein
inferredcites →https://doi.org/10.1158/1078-0432.ccr-12-2986openalex-snapshot
Identification of Prognosis-Relevant Subgroups in Patients with Chemoresistant Triple-Negative Breast Cancer
inferredcites →https://doi.org/10.1158/1535-7163.mct-14-0928openalex-snapshot
MCL-1 Is a Key Determinant of Breast Cancer Cell Survival: Validation of MCL-1 Dependency Utilizing a Highly Selective Small Molecule Inhibitor
inferredcites →https://doi.org/10.1182/blood-2018-06-859405openalex-snapshot
Humanized Mcl-1 mice enable accurate preclinical evaluation of MCL-1 inhibitors destined for clinical use
inferredcites →https://doi.org/10.1186/s13045-020-01007-9openalex-snapshot
MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents
inferredcites →https://doi.org/10.1186/s13045-021-01079-1openalex-snapshot
Targeting MCL-1 in cancer: current status and perspectives
inferredcites →https://doi.org/10.18632/aging.204207openalex-snapshot
Synergism of BCL-2 family inhibitors facilitates selective elimination of senescent cells
inferredcites →https://doi.org/10.3109/10611860903156419openalex-snapshot
Receptor mediated uptake of paclitaxel from a synthetic high density lipoprotein nanocarrier
inferredcites →https://doi.org/10.3892/ijo.11.3.497openalex-snapshot
Enhanced albumin uptake by rat tumors

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1038/s41584-023-01067-4openalex-snapshot
Engineering approaches for RNA-based and cell-based osteoarthritis therapies
inferred← citeshttps://doi.org/10.1101/2023.05.31.542971openalex-snapshot
Albumin-binding RNAi Conjugate for Carrier Free Treatment of Arthritis
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.